Clinical Trial Update: Safety and Efficacy Challenge Study of Live Oral Cholera Vaccine Candidate,PXVX0200, to Prevent Cholera [Phase 3]

View source ↗

Summary

Phase 3 trial of live oral cholera vaccine candidate PXVX0200 completed; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholera

Drugs mentioned

• PXVX0200

Snippet

Sponsor: Bavarian Nordic | Conditions: Cholera | Phase 3 | Status: COMPLETED | Results posted: 2021-04-01